D
recently approved a drug that can quickly cure hepatitis C in many patients
Debate over about ‘how to price a cure’ entered the pharma industry lexicon when Gilead Sciences Inc
23 Olysio is slightly less effective than Sovaldi, as it is not recommended to treat Hepatitis C genotype 1a
Sofosbuvir (Sovaldi) is an antiviral medication prescribed in combination with other hep C drugs to treat and possibly cure hepatitis C viral infection (HCV)
[1] Chronic hepatitis B (CHB) is a long-lasting infection and occurs when the body’s immune system is unable to fight off the virus and it persists in the blood and liver
But of the 50,000-60,000 patients to be treated in the first phase, only around 0
But in some people, it turns into a chronic infection that never goes away
In studies, these cure rates were seen in Hepatitis means inflammation of the liver
Of note, the activity against genotype 3 appears less than with genotype 2 and treatment of genotype 3 infection requires a longer all-oral course of treatment than with genotype 2
HBV reactivation has been reported in HCV/HBV coinfected patients who were undergoing or had completed
Sovaldi got attention for its list price of $1,000 per pill, or $84,000 for a full 12-week regimen
Sovaldi, when used with another drug, can cure most cases of hepatitis C in 12 weeks with few side effects
But for others, the infection becomes chronic, meaning it lasts more than six months